Rifagut Tablets (Generic Rifaximin Tablets)

Rifagut Tablets During Pregnancy

Rifaximin (Rifagut tablets) is classified by the US FDA as Pregnancy

Category C.

There are no adequate and well controlled studies conducted in pregnant women. Rifaximin has been shown to be teratogenic in rats and rabbits at doses that caused maternal toxicity. Rifaximin tablets (Rifagut tablets) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

It is not known at present if Rifaximin is excreted in human milk. Because many medicines are excreted in human milk and because of the potential for adverse reactions in nursing infants from Generic Rifaximin, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the medicine to the mother.

URL: https://www.clearskypharmacy.biz/generic-xifaxan-rifagut-by-sun-pharma.html